Breast Cancer Risk Assessment Tool

Assess your lifetime and 5-year breast cancer risk using validated risk assessment models. Essential tool for preventive health screening.

Note: This tool uses a simplified version of validated risk assessment models (Gail model and Tyrer-Cuzick model). Results are estimates and should not replace clinical evaluation by a healthcare professional.

Personal Information

Age at which risk is being assessed (20-90 years)
Different ethnic groups have different baseline risks

Reproductive History

Mother, sisters, daughters
Include biopsies with benign results

Additional Risk Factors

Calculating risk assessment...

Understanding Breast Cancer Risk

Breast cancer risk assessment helps identify women who may benefit from more intensive screening or preventive measures. Risk is influenced by a combination of genetic, hormonal, reproductive, and lifestyle factors.

Key Risk Factors:

  • Age: Risk increases with age, with most breast cancers diagnosed after age 50
  • Family History: Having a first-degree relative with breast cancer increases risk
  • Genetic Mutations: Inherited mutations in BRCA1, BRCA2, and other genes
  • Reproductive History: Early menstruation, late menopause, late or no childbirth
  • Breast Density: Women with dense breast tissue have higher risk

Risk Categories and Clinical Implications

Risk Category 5-Year Risk Lifetime Risk Clinical Implications
Below Average < 1.0% < 12% Average screening recommendations apply
Average 1.0-1.66% 12-15% Average screening recommendations apply
Moderate 1.67-2.49% 15-20% Consider enhanced surveillance
High 2.5-4.99% 20-30% Enhanced surveillance, consider risk reduction strategies
Very High ≥ 5.0% ≥ 30% Consider genetic counseling, intensive surveillance, risk reduction medications/surgery

Validated Risk Assessment Models

Several validated models are used clinically to estimate breast cancer risk:

1

Gail Model: Estimates risk based on age, reproductive factors, family history, and biopsy history. Used for determining eligibility for risk-reducing medications.

2

Tyrer-Cuzick Model: Incorporates more detailed family history including second-degree relatives and ovarian cancer. Better for assessing genetic predisposition.

3

BRCAPRO Model: Specifically estimates likelihood of BRCA1/BRCA2 mutations based on family history of breast and ovarian cancer.

4

Claus Model: Estimates risk based on family history, particularly useful when detailed family history is available.

Risk Reduction Strategies

  • Lifestyle Modifications:
    • Maintain healthy weight
    • Regular physical activity
    • Limit alcohol consumption
    • Breastfeeding when possible
  • Medical Interventions:
    • Risk-reducing medications (tamoxifen, raloxifene)
    • Enhanced screening (MRI in addition to mammography)
    • Preventive surgery (for very high-risk women)

Clinical Note: This tool provides risk estimates based on statistical models. Individual risk may vary. Consult with a healthcare provider for personalized risk assessment and screening recommendations. Women at increased risk may benefit from genetic counseling and more intensive screening.

Frequently Asked Questions

Absolute risk is the actual probability of developing breast cancer over a specific time period (e.g., 5-year risk or lifetime risk). Relative risk compares your risk to that of an average woman of the same age and ethnicity. For example, a relative risk of 2.0 means you have twice the risk of an average woman.

For women at average risk, most guidelines recommend starting annual or biennial mammograms at age 40-50. Women at higher than average risk may need to start earlier and have more frequent screening, often including breast MRI. Consult with your healthcare provider for personalized recommendations based on your risk assessment.

Genetic testing may be appropriate if you have: a personal history of breast cancer at a young age, triple-negative breast cancer, ovarian cancer, male breast cancer, or a strong family history of breast/ovarian cancer. Genetic counseling is recommended before testing to understand the implications. This risk assessment tool can help identify if you might benefit from genetic counseling.

Dense breast tissue means you have more glandular and fibrous tissue relative to fatty tissue. This is common and normal, but it increases breast cancer risk and can make mammograms harder to interpret. Women with dense breasts may benefit from supplemental screening with ultrasound or MRI. Your mammogram report will indicate if you have dense breast tissue.

Yes, many risk factors are modifiable. Maintaining a healthy weight, regular physical activity, limiting alcohol, avoiding postmenopausal hormone therapy, and breastfeeding can reduce risk. For women at high risk, medications like tamoxifen or raloxifene can reduce risk by 30-50%. Very high-risk women may consider risk-reducing mastectomy. Discuss options with your healthcare provider.